Antero Resources Corporation (LON:0A71)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,853	8,712	5,351	7,720	4,057	1,072
Market Cap Growth	39.73%	62.79%	-30.68%	90.27%	278.31%	67.44%
Enterprise Value	10,624	12,288	9,257	11,848	8,190	5,566
Last Close Price	25.21	28.00	17.89	25.63	12.95	-
PE Ratio	22.47	190.58	34.36	4.97	-	-
PS Ratio	2.21	2.54	1.52	1.07	0.84	0.43
PB Ratio	1.44	1.51	0.96	1.33	0.91	0.24
P/TBV Ratio	1.47	1.55	0.99	1.38	0.95	0.25
P/FCF Ratio	15.87	82.31	-	4.41	5.82	-
P/OCF Ratio	7.72	12.84	6.85	3.05	3.31	1.99
EV/Sales Ratio	2.89	3.58	2.63	1.64	1.70	2.24
EV/EBITDA Ratio	4.34	18.78	9.44	4.16	12.86	50.58
EV/EBIT Ratio	22.33	2657.04	26.30	5.57	427.64	-
EV/FCF Ratio	21.47	116.10	-	6.77	11.75	-
Debt / Equity Ratio	0.51	0.56	0.63	0.66	0.91	0.92
Debt / EBITDA Ratio	1.33	1.51	1.49	0.91	2.23	3.14
Debt / FCF Ratio	11.04	30.44	-	2.20	5.87	-
Asset Turnover	0.35	0.32	0.33	0.62	0.48	0.24
Quick Ratio	0.37	0.34	0.31	0.42	0.32	0.46
Current Ratio	0.39	0.35	0.33	0.44	0.33	0.58
Return on Equity (ROE)	3.79%	1.31%	4.20%	30.56%	-2.54%	-19.30%
Return on Assets (ROA)	1.06%	0.03%	2.03%	11.45%	0.12%	-4.14%
Return on Capital (ROIC)	1.23%	0.03%	2.41%	13.78%	0.14%	-4.63%
Return on Capital Employed (ROCE)	1.90%	0.10%	3.70%	20.80%	0.20%	-
Earnings Yield	4.45%	0.53%	2.91%	20.12%	-3.40%	-86.59%
FCF Yield	6.30%	1.21%	-2.01%	22.66%	17.19%	-9.47%
Buyback Yield / Dilution	-0.71%	-0.58%	5.35%	-6.84%	-13.11%	11.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.